“…PDR prevalence was around 20% and CSMO prevalence was around 18%, compared with 1-8% and 6%, respectively, in the population. [29][30][31][32][33][34][35] It is also difficult to make international comparisons for hospital DR prevalence data, as each country's health system has a different approach to thresholds for referral; hence, the proportion of patients with diabetes managed by the HES will be different from the proportion managed via primary care. The proportions of patients with DR managed by the UK HES should in theory be more consistent, as national screening programmes have been implemented to invite the whole UK population of patients with diabetes for screening and to refer to the HES only those with potentially sight-threatening retinopathy.…”